CL2015003736A1 - Sales de nalmefeno como medicamentos para reducir el consumo de alcohol o para prevenir el consumo excesivo de alcohol - Google Patents
Sales de nalmefeno como medicamentos para reducir el consumo de alcohol o para prevenir el consumo excesivo de alcoholInfo
- Publication number
- CL2015003736A1 CL2015003736A1 CL2015003736A CL2015003736A CL2015003736A1 CL 2015003736 A1 CL2015003736 A1 CL 2015003736A1 CL 2015003736 A CL2015003736 A CL 2015003736A CL 2015003736 A CL2015003736 A CL 2015003736A CL 2015003736 A1 CL2015003736 A1 CL 2015003736A1
- Authority
- CL
- Chile
- Prior art keywords
- alcohol consumption
- medicines
- prevent excessive
- reduce
- nalmefene salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
Abstract
SAL DEL COMPUESTO NALMEFENO, QUE NO FORMA HIDRATOS NI SOLVATOS; COMPOSICION FARMACEUTICA QUE LA COMPRENDE; SU USO PARA REDUCIR EL CONSUMO DE ALCOHOL EN UN PACIENTE CON ALCOHOLISMO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA201300421 | 2013-07-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2015003736A1 true CL2015003736A1 (es) | 2016-08-19 |
Family
ID=51177066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2015003736A CL2015003736A1 (es) | 2013-07-11 | 2015-12-28 | Sales de nalmefeno como medicamentos para reducir el consumo de alcohol o para prevenir el consumo excesivo de alcohol |
Country Status (27)
Country | Link |
---|---|
US (2) | US9725458B2 (es) |
EP (1) | EP3019500B1 (es) |
JP (1) | JP6491653B2 (es) |
KR (1) | KR20160030130A (es) |
CN (1) | CN105377854B (es) |
AR (1) | AR096851A1 (es) |
AU (1) | AU2014289182B2 (es) |
CA (1) | CA2917576C (es) |
CL (1) | CL2015003736A1 (es) |
CY (1) | CY1122099T1 (es) |
DK (1) | DK3019500T3 (es) |
EA (1) | EA031747B1 (es) |
ES (1) | ES2749614T3 (es) |
HR (1) | HRP20191764T1 (es) |
HU (1) | HUE046904T2 (es) |
IL (1) | IL243243B (es) |
LT (1) | LT3019500T (es) |
ME (1) | ME03504B (es) |
MX (1) | MX2016000006A (es) |
PH (1) | PH12016500052A1 (es) |
PL (1) | PL3019500T3 (es) |
PT (1) | PT3019500T (es) |
RS (1) | RS59349B1 (es) |
SG (1) | SG11201600116VA (es) |
SI (1) | SI3019500T1 (es) |
TW (1) | TW201536288A (es) |
WO (1) | WO2015004240A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR096851A1 (es) | 2013-07-11 | 2016-02-03 | H Lundbeck As | Sales que no forman hidratos ni solvatos de nalmefeno |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU196376B (en) * | 1985-05-23 | 1988-11-28 | Sandoz Ag | Process for preparing morphinane derivatives and pharmaceutical compositions containing such compounds |
JP2005508888A (ja) | 2001-08-14 | 2005-04-07 | バイオティ セラピーズ コーポレイション | アルコール依存症またはアルコール中毒を治療する方法 |
KR101598138B1 (ko) * | 2008-04-24 | 2016-02-29 | 얀센 파마슈티카 엔.브이. | 날메펜 디에스테르 프로드럭 |
GB0814043D0 (en) * | 2008-07-31 | 2008-09-10 | Serentis Ltd | The treatment of skin disorders |
UA102128C2 (en) * | 2008-12-05 | 2013-06-10 | Х. Луннбек А/С | Nalmefene hydrochloride dihydrate |
SI2435439T1 (sl) | 2009-05-25 | 2016-06-30 | H. Lundbeck A/S | Priprava nalmefen hidroklorida iz naltreksona |
AU2011325563B2 (en) | 2010-11-05 | 2015-08-20 | H. Lundbeck A/S | Method for the manufacturing of naltrexone |
CN103012416B (zh) | 2011-09-28 | 2015-07-01 | 辽宁海思科制药有限公司 | 一种盐酸纳美芬的制备方法 |
AR096851A1 (es) | 2013-07-11 | 2016-02-03 | H Lundbeck As | Sales que no forman hidratos ni solvatos de nalmefeno |
-
2014
- 2014-07-08 AR ARP140102531A patent/AR096851A1/es unknown
- 2014-07-10 SG SG11201600116VA patent/SG11201600116VA/en unknown
- 2014-07-10 EA EA201592228A patent/EA031747B1/ru not_active IP Right Cessation
- 2014-07-10 ME MEP-2019-252A patent/ME03504B/me unknown
- 2014-07-10 HU HUE14738819A patent/HUE046904T2/hu unknown
- 2014-07-10 WO PCT/EP2014/064819 patent/WO2015004240A1/en active Application Filing
- 2014-07-10 LT LT14738819T patent/LT3019500T/lt unknown
- 2014-07-10 RS RSP20191242 patent/RS59349B1/sr unknown
- 2014-07-10 KR KR1020157037096A patent/KR20160030130A/ko not_active Application Discontinuation
- 2014-07-10 TW TW103123770A patent/TW201536288A/zh unknown
- 2014-07-10 MX MX2016000006A patent/MX2016000006A/es unknown
- 2014-07-10 US US14/903,384 patent/US9725458B2/en active Active
- 2014-07-10 CA CA2917576A patent/CA2917576C/en active Active
- 2014-07-10 ES ES14738819T patent/ES2749614T3/es active Active
- 2014-07-10 CN CN201480039127.2A patent/CN105377854B/zh active Active
- 2014-07-10 AU AU2014289182A patent/AU2014289182B2/en not_active Ceased
- 2014-07-10 EP EP14738819.3A patent/EP3019500B1/en active Active
- 2014-07-10 DK DK14738819.3T patent/DK3019500T3/da active
- 2014-07-10 JP JP2016524824A patent/JP6491653B2/ja active Active
- 2014-07-10 SI SI201431368T patent/SI3019500T1/sl unknown
- 2014-07-10 PL PL14738819T patent/PL3019500T3/pl unknown
- 2014-07-10 PT PT147388193T patent/PT3019500T/pt unknown
-
2015
- 2015-12-20 IL IL243243A patent/IL243243B/en active IP Right Grant
- 2015-12-28 CL CL2015003736A patent/CL2015003736A1/es unknown
-
2016
- 2016-01-07 PH PH12016500052A patent/PH12016500052A1/en unknown
-
2017
- 2017-06-12 US US15/619,645 patent/US9938286B2/en active Active
-
2019
- 2019-09-27 HR HRP20191764TT patent/HRP20191764T1/hr unknown
- 2019-10-03 CY CY20191101030T patent/CY1122099T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2016001079A1 (es) | Nuevos compuestos para el combate de artrópodos. | |
CL2016000153A1 (es) | Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis b | |
BR112015030268A2 (pt) | composição farmacêutica, recipiente, kit, e, método para a preparação de uma composição | |
GT201500247A (es) | Imidazopiridazinas sustituidas | |
CU20150061A7 (es) | PIRIMIDO-[4,5-b]-QUINOLINA-4,5(3H,10H)-DIONAS COMO SUPRESORAS DE MUTACIÓN SIN SENTIDO | |
CL2016001210A1 (es) | Análogos de bicalutamida o (s)- bicalutamida como compuestos activadores de la exocitosis para su uso en el tratamiento de un desorden de acúmulo lisosomal o glucogenosis. | |
CL2016000019A1 (es) | Compuestos derivados de dihidroxifenilo deuterado o una sal de los mismos; composición farmacéutica que los comprende y su uso para el tratamiento de trastornos mediados por neurotransmisores tales como hipotensión, trastornos del sueño, enfermedad de alzheimer y depresión. | |
CL2016002677A1 (es) | Compuestos heteroaromáticos y su uso como ligandos de dopamina d1. | |
CR20160227A (es) | Nuevo compuesto para el tratamiento de hipoglicemia severa | |
GT201600117A (es) | Nuevo compuesto para el tratamiento de hipoglicemia severa | |
ECSP16024805A (es) | Nuevo compuesto para el tratamiento de hipoglicemia severa | |
CL2015003736A1 (es) | Sales de nalmefeno como medicamentos para reducir el consumo de alcohol o para prevenir el consumo excesivo de alcohol | |
CL2016001054A1 (es) | Compuestos para el tratamiento de diabetes y complicaciones de enfermedades derivadas de la misma | |
CL2016000171A1 (es) | Formulación de metaxalona. | |
BR112015023730A2 (pt) | uso de sedoeptulose como suplemento nutricional | |
UY34752A (es) | Agentes para el control de la chinche del eucalipto | |
RU2014118884A (ru) | Средство для снижения алкогольной мотивации при алкогольной зависимости | |
CR20150352A (es) | Nuevas composiciones antifúngicidas | |
CR20130615S (es) | Contenedor | |
HOUT et al. | To See or Not to See | |
TH1601000022A (th) | เกลือของนาลมีฟีนในฐานะยาสำหรับการลดการบริโภคแอลกอฮอล์หรือสำหรับ การป้องกันการบริโภคแอลกอฮอล์มากเกินไป | |
NI201300117S (es) | Cuello rosca para todo tipo de envase | |
BR302013000353S1 (pt) | "configuração aplicada em embalagem para bebidas." | |
TH1601002316A (th) | การใช้พอลิเตตระไฮโดรฟิวเเรนที่ถูกแอลคอกซิเลตเพื่อลดการใช้เชื้อเพลิง | |
CR20110525S (es) | Termo para almacenar liquidos |